Login / Signup

Should we lose hope in adjuvant therapy for neuroendocrine tumors?-In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit.

Giuseppe LambertiLisa ManuzziIlaria MaggioDavide Campana
Published in: Journal of surgical oncology (2020)
Keyphrases
  • neuroendocrine tumors
  • free survival
  • early stage